F. Wussow

发表

Red-Mediated Transposition and Final Release of the Mini-F Vector of a Cloned Infectious Herpesvirus Genome

H. Fickenscher, B. K. Tischer, F. Wussow, 2009, PloS one.

Seamless manipulation of the varicella-zoster virus genome via bacterial artificial chromosome engineering

F. Wussow, 2009 .

COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants

Mark G. Lewis, H. Andersen, D. Diamond, 2022, iScience.

Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complex.

P. Barry, D. Diamond, Joybelle Martinez, 2018, Journal of virological methods.

A Vaccine Based on the Rhesus Cytomegalovirus UL128 Complex Induces Broadly Neutralizing Antibodies in Rhesus Macaques

A. Herrmann, P. Barry, J. Longmate, 2012, Journal of Virology.

Induction of poxviral immunity by synthetic MVA-based dual-antigen COVID-19 vaccine COH04S1

J. Zaia, D. Diamond, F. Chiuppesi, 2022, medRxiv.

Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants

Anna M. Acosta, P. Frankel, J. Zaia, 2022, iScience.

Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells

D. Diamond, Heidi Contreras, F. Chiuppesi, 2017, Vaccines.

Chimeric Antigen Receptors Targeting Human Cytomegalovirus.

O. Yang, Ayub Ali, D. Diamond, 2020, The Journal of infectious diseases.

Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys

K. Koelle, M. Cohen-Wolkowiez, P. Barry, 2017, bioRxiv.

Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice

P. Bjorkman, P. Barry, D. Diamond, 2017, PloS one.

Human Cytomegalovirus Vaccine Based on the Envelope gH/gL Pentamer Complex

A. Herrmann, Erica L Johnson, P. Barry, 2014, PLoS pathogens.

Cytomegalovirus (CMV)-Vectored vaccines for HIV and other pathogens.

D. Hartigan-O’Connor, P. Barry, D. Diamond, 2020, AIDS.

Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission

J. Estroff, D. O’Connor, M. Lauck, 2015, Proceedings of the National Academy of Sciences.

Bacterial Genetics of Large Mammalian DNA Viruses: Bacterial Artificial Chromosomes as a Prerequisite for Efficiently Studying Viral DNA Replication and Functions

H. Fickenscher, T. Toptan, F. Wussow, 2011 .

A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits.

Peng Ye, Joslyn Foley, J. Totonchy, 2019, Vaccine.

Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types

M. Brehm, Joslyn Foley, J. Totonchy, 2019, Journal of Virology.

A Self-Excisable Infectious Bacterial Artificial Chromosome Clone of Varicella-Zoster Virus Allows Analysis of the Essential Tegument Protein Encoded by ORF9

N. Osterrieder, B. Kaufer, B. K. Tischer, 2007, Journal of Virology.

Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice

D. Diamond, Heidi Contreras, Soojin Park, 2018, Journal of Virology.

Modeling Human Cytomegalovirus-Induced Microcephaly in Human iPSC-Derived Brain Organoids

F. Gage, G. Ming, Hongjun Song, 2020, Cell reports. Medicine.

A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection

J. Zaia, D. Diamond, Sanjeet S. Dadwal, 2018, Expert review of vaccines.

Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates

P. Frankel, H. Andersen, D. Diamond, 2022, NPJ vaccines.

Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates

P. Frankel, H. Andersen, D. Diamond, 2021, npj Vaccines.

Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform

Xiwei Wu, E. Manuel, D. Diamond, 2020, Nature Communications.

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.

I. Aldoss, J. Zaia, J. Longmate, 2017, Blood.

Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform

Xiwei Wu, E. Manuel, D. Diamond, 2020, Research square.

Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine

Xiwei Wu, E. Manuel, D. Diamond, 2020, bioRxiv.

Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants

D. Diamond, F. Chiuppesi, F. Wussow, 2023, npj Vaccines.

Comparison of Monovalent Glycoprotein B with Bivalent gB/ pp65 (GP83) Vaccine for Congenital Cytomegalovirus Infection in a Guinea Pig Model: Inclusion of GP83 Reduces Antibody Response but Provides Equivalent Protection Against Mortality

Megan M. Schmit, P. Gillis, D. Diamond, 2016 .

Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.

Megan M. Schmit, M. Schleiss, P. Gillis, 2015, Vaccine.

Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine.

M. Schleiss, P. Gillis, D. Diamond, 2014, Vaccine.

MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission

M. Schleiss, D. Diamond, Heidi Contreras, 2019, Vaccines.

Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus

P. Barry, D. Diamond, F. Chiuppesi, 2017, Journal of Virology.

Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial

A. Sette, P. Frankel, J. Zaia, 2022, The Lancet Microbe.

Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection

W. Britt, Erica L Johnson, P. Barry, 2015, Journal of Virology.

Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys

K. Koelle, Meng Chen, M. Cohen-Wolkowiez, 2017, bioRxiv.

Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission

T. Gurley, M. A. Moody, Joshua D. Amos, 2017, Clinical and Vaccine Immunology.

Protection against Congenital CMV Infection Conferred by MVA-Vectored Subunit Vaccines Extends to a Second Pregnancy after Maternal Challenge with a Heterologous, Novel Strain Variant

M. Schleiss, D. Diamond, Heidi Contreras, 2021, Viruses.

Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection

W. Britt, Erica L Johnson, P. Barry, 2015, Journal of Virology.

Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys

K. Koelle, Meng Chen, M. Cohen-Wolkowiez, 2017, bioRxiv.

M. Schleiss, P. Gillis, D. Diamond, 2014, Vaccine.

Preexisting antibodies can protect against congenital cytomegalovirus infection in 3 monkeys 4 5

K. Koelle, Meng Chen, M. Cohen-Wolkowiez, 2017 .